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To estimate the prevalence of nonadherence to treatment and its relationship with social
support and social context in patients with multimorbidity and polypharmacy followed-up in
primary care.
Methods
This was an observational, descriptive, cross-sectional, multicenter study with an analytical
approach. A total of 593 patients between 65–74 years of age with multimorbidity (�3 dis-
eases) and polypharmacy (�5 drugs) during the last three months and agreed to participate
in the MULTIPAP Study. The main variable was adherence (Morisky-Green). The predictors
were social support (structural support and functional support (DUFSS)); sociodemographic
variables; indicators of urban objective vulnerability; health-related quality of life (EQ-5D-5L-
VAS & QALY); and clinical variables. Descriptive, bivariate and multivariate analyses with
logistic regression models and robust estimators were performed.
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Results
Four out of ten patients were nonadherent, 47% had not completed primary education,
28.7% had an income�1050 €/month, 35% reported four or more IUVs, and the average
perceived health-related quality of life (HRQOL) EQ-5D-5L-VAS was 65.5. The items that
measure functional support, with significantly different means between nonadherent and
adherent patients were receiving love and affection (-0.23; 95%CI: -0.40;-0.06), help when
ill (-0.25; 95%CI: -0.42;-0.08), useful advice (-0.20; 95%CI: -0.37;-0.02), social invitations
(-0.22; 95%CI:-0.44;-0.01), and recognition (-0.29; 95%CI:-0.50;-0.08). Factors associated
with nonadherence were belonging to the medium vs. low tertile of functional support (0.62;
95%CI: 0.42;0.94), reporting less than four IUVs (0.69; 95%CI: 0.46;1.02) and higher
HRQOL perception (0.98; 95%CI: 0.98;0.99).
Conclusions
Among patients 65–74 years of age with multimorbidity and polypharmacy, lower functional
support was related to nonadherence to treatment. The nonadherence decreased in those
patients with higher functional support, lower urban vulnerability and higher perceived health
status according to the visual analog scale of health-related quality of life.
Introduction
Population aging has led multimorbidity to be becoming increasingly prevalent in the adult
population of most Western European countries [1]. Most studies define multimorbidity as
the concurrent presence of two or more, or three or more chronic diseases; the latter definition
is more suitable for the identification of patients with complex health needs [2]. It is estimated
that the average number of chronic conditions in those over 75 years is 3.2, while that for the
young seniors (65–74 years) is 2.8 [1–3]. Multimorbidity affects 81.5% of people older than 85
years, 62% of those 65–74 years old and 50% of those younger than 65 years old [4]. Multimor-
bidity is associated with polypharmacy, defined as the simultaneous consumption of five or
more drugs [5]. Polypharmacy has undesirable consequences, such as increased risk of poten-
tially inappropriate medication, misuse of doses, either by excess or by default of necessary
treatments, nonadherence and increased risk of interactions and adverse drug reactions [6].
Studies on different population groups with respect to age and chronic condition showed
an average of 50% adherence to long-term therapy. They found that about half of the chronic
patients do not comply with their prescription or do so incorrectly, particularly with respect to
time, dose, frequency and duration [7,8]. Nonadherence to prescribed treatment is a growing
and complex problem for both patients and healthcare systems [9,10]. Haynes et al. [11] identi-
fied more than 250 factors that can influence drug adherence, among which being older and
social isolation stood out as the most important ones [12]. Components of the social context
are all those that encompass the individual’s living conditions: the physical environment in
which they live, the socio-economic level, the level of education, work, income level, the social
network and social support [13]. The challenge of improving adherence has traditionally
focused on the individual characteristics of the patient, the complexity of the treatment, the
type of information provided, health literacy, and the physician-patient relationship [14,15],
with social factors being little explored [8,16]. Thus far, some studies have found a significant
relationship between adherence and the social context, in terms of socioeconomic status [17]
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and social support [18,19]. However, there are few studies exploring the impact of all these
determinants together, which hinders the comprehensive approach necessary to study nonad-
herence to treatment [20].
The definition of social support includes whether the basic social needs of a person (affec-
tion, esteem, approval, belonging, identity and safety) are satisfied through the interaction
with others [21]. It covers three areas: (1) structural, which assesses the number and pattern of
direct and indirect bonds surrounding the individual; (2) functional, which corresponds to the
different types of resources that flow through the bonds of the social network; and (3) informa-
tive, which reflects the knowledge provided to the individual through his or her social network
[22,23]. Two meta-analyses have analyzed the relationship between social support and adher-
ence to treatment, concluding that adherence improves more significantly with functional sup-
port than with structural support [20,24]. Having someone to talk to and have contact with, as
well as someone who in turn provides emotional support, seem to play a prominent role in the
association of functional support and adherence to treatment [18]. Moreover, the source of
functional support and the type of help that is received also have a considerable influence on
this association [19,24,25]. In this sense, jointly studying the different elements of the social
context and exhaustively exploring the influence of functional support on nonadherence could
be key to better understand this complex framework and the role that each factor plays in ther-
apeutic adherence [19]. The main objective of this study is to estimate the prevalence of nonad-
herence to treatment and its relationship with social support and social context in patients
with multimorbidity and polypharmacy followed-up in primary care.
Materials and methods
An observational, descriptive, cross-sectional study with an analytical approach was performed
using baseline data from the MULTIPAP Study [26]. This study was a pragmatic group-con-
trolled, randomized clinical trial with 12 months of follow-up conducted in 38 health centers
in the regions of Andalucı́a, Aragon and Madrid (Spain) with the participation of 117 family
physicians (GPs), each recruiting five patients. Patients aged 65–74 years with multimorbidity
(�3 chronic diseases) and polypharmacy (�5 different drugs for at least the last three months)
who visited their GP at least once in the last year and had given their written informed consent
to participate in the MULTIPAP Study were included [26]. We excluded institutionalized
patients with severe mental illness and those with a life expectancy of less than 12 months
according to their physician. Patients were selected by random sampling among those who
met the inclusion criteria. All the variables described below were collected by the GP through
an interview during the consultation. The participating GPs were previously trained to con-
duct the interview through an electronic data collection notebook.
The main outcome variable was adherence to treatment (adherent/nonadherent), measured
with the Morisky-Green test. The Morisky-Green questionnaire asks a series of closed ques-
tions to the patient: “do you ever forget to take the medicines to treat your illness; do you take the
medicines at the indicated times; when you feel well, do you stop taking the medicine; if you ever
feel bad, do you stop taking the medicine? Patients are considered adherent if they answer all
four questions correctly and non-adherent if they answer three or fewer questions” [27]. The
main independent variable was social support, measured in two ways: structural support
(information about marital status and number of cohabitants in the home) and functional sup-
port. The latter was measured through the Duke UNC-11 Functional Social Support (DUFSS).
This questionnaire offers a total score of functional support and two additional scores related
to each of the domains revealed by its factor analysis: confidential and affective support [28].
The version used in this study was composed of 11 items. Each item uses a Likert-type
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response scale from 1 (“Much less than I would like”) to 5 (“As much as I would like”) [29].
Since its creation to date, the instrument has been validated in very different populations,
showing differences in the distribution of the items that make up each of the domains. Valida-
tion performed by Ayala et al. [30] was carried out in a noninstitutionalized Spanish popula-
tion, with an average age of 72 years. As this is a population similar to ours, we have used the
result of their factor analysis, in which confidential support is measured through seven items
(4, 5, 6, 7, 8, 10 and 11), with a total score of 35, and affective support is measured through 4
items (1, 2, 3, and 9), with a total score of 20. The total score for social support was categorized
in tertiles, being tertile 1 the lowest.
The following potential predictor variables were considered: a) sociodemographic variables
such as age, sex, retirement status (retirement/no retirement), social class (collected through
the 7 categories of the CNO-SEE12 instrument and subsequently grouped) [31], education
level (primary education incomplete, primary education, secondary or higher education), and
socioeconomic level (�1050€/month, 1051–2250€/month and�2251€/month); b) indicators
of subjective urban vulnerability (IUVs), based on those collected by the National Health Sur-
vey to explore participants’ neighborhood (noise level, odors, poor-quality drinking water,
unclean streets, air pollution, lack of green areas, feral animals and crime) [32]; and c) clinical
factors (number of chronic diseases and number of drugs consumed) and health-related qual-
ity of life (HRQOL) measured by the EQ-5D-5L [33]. The EQ-5D-5L determines the perceived
general state of health measured by a visual analog scale (VAS) and utilities.
A descriptive analysis of the characteristics of the patients was performed, with frequencies
and percentages for the qualitative variables and with means and standard deviations (SD) or
medians and interquartile ranges (IQR) for the quantitative variables according to their distri-
bution. The prevalence of nonadherence was estimated with the 95% confidence intervals
(CI). The contrast of qualitative variables was performed with the Pearson Chi-squared test,
and the contrast of normally distributed quantitative variables was performed with Student’s t-
test. To study the association between functional support (independent variable) and nonad-
herence (dependent variable), a logistic regression model was fit with sequential forward fitting
in three steps. Model 1 was adjusted for sociodemographic factors (age, sex, retirement status,
social class, education level and socioeconomic status). Model 2 was adjusted additionally for
IUVs (<4 vs.�4 indicators). A final model was constructed (model 3) adjusting additionally
for clinical factors (number of diseases and number of drugs) and health-related quality of life.
Considering that the patients were included in the study by cluster-sampling (each GP
included five patients), robust estimators were obtained. The data analysis was performed with
the statistical software STATA v14.
Ethical and legal aspects
The project was approved by the Clinical Research Ethics Committee of Aragon (CEICA) on
September 30, 2015, with the reference number PI15/0217. And has been favorably evaluated
by the Research Ethics Committee of the Province of Malaga on September 25, 2015, and by
the Central Committee of Primary Care Research of the Community of Madrid.
Results
Of the 593 patients included in the study, a total of 40.8% (95% CI: 36.9%; -44.8%) were non-
adherent. Table 1 shows the distribution of variables and the number of subjects (total popula-
tion, nonadherent and adherent). More than half of the sample (56.3%) were women, and the
mean age was 69.7 years (SD 2.7 years). Compared to adherent patients, those who were non-
adherent reported a higher percentage of 4 or more IUVs (48.3% vs. 36.8%, p = 0.007) and had
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Table 1. Characteristics of patients according to adherence.
Total n (%) Adherent n (%) Nonadherent n (%) p-value
N 593(100) 351(59.2) 242(40.8)
Age � 69.7(2,7) 69.8(2.7) 69.6(2.7) 0.55
Sex
Male 259(43.7) 153(59.1) 106(40.9) 0.96
Female 334 (56.3) 198(59.3) 136(40.7)
Retirement status
Retired 538(90.7) 321(59.7) 217(40.3) 0.46
Nonretired 55(9.3) 30(54.6) 25(45.5)
Social class
Mid-level supervisors and directors 234(39.5) 147(62.8) 87(37.2) 0.33
Skilled primary sector 217(36.6) 125(57.6) 92(42.4)
Unskilled 142(24) 79(55.6) 63(44.4)
Education level 74(12.5) 43(58.1) 31(41.9)
Primary education incomplete 279(47.1) 163(58.4) 116(41.6) 0.88
Primary education 240(40.5) 145(60.4) 95(39.6)
Secondary or higher education
Socioeconomic level
�2251€/month 59(10) 37(62.7) 22(37.3)
1051–2250€/month 342(57.7) 199(58.2) 143(41.8) 0.45
�1050€/month 170(28.7) 105(61.8) 65(38.2)
NS/NC 22(3.7) 10(45.5) 12(54.6)
Urban vulnerability indicators
<4 indicators 386(65.1) 244(63.2) 142(36.8) <0.01
�4 indicators 207(34.9) 107(51.7) 100(48.3)
Number of diseases�� 6(4–7) 6(4–7) 5.5(4–7) 0.99
Number of diseases� 6.1(2.5) 6.1(2.5) 6.1(2.4) 1.00
Number of drugs�� 7(6–9) 7(5–9) 7(6–9) 0.92
Number of drugs� 7.4(2.4) 7.5(2.5) 7.4(2.2) 0.57
HRQOL �
EQ-5D-5L-VAS 65.5(20.5) 68.3(19.7) 61.5(21.1) <0.01
Utilities 0.77(0.2) 0.79(0.2) 0.75(0.2) 0.02
Structural social support
Cohabitation
Lives alone 106(17.9) 59(55.7) 47(44.3) 0.72
Lives with 1 person 368(62.1) 221(60) 147(40)
Lives with�2 people 119(20.1) 71(59.7) 48(40.3)
Marital status
Single 23(3.9) 11(47.8) 12(52.2) 0.72
Married or partner 447(75.4) 268(60) 179(40)
Separated 29(4.9) 17(58.6) 12(41.4)
Widow 94(15.8) 55(58.5) 39(41.5)
Functional social support (DUFSS)
Total score� 43.7(8.8) 44.5(8.1) 42.7(9.6) 0.01
1st tertile (low) 190(32) 97(51.1) 93(49)
2nd tertile (medium) 191(32.2) 123(64.4) 68(35.6) 0.01
3rd tertile (high) 212(35.8) 131(61.8) 81(38.2)
Confidential score� 29.5(5.9) 30(5.5) 28.8(6.4) 0.03
(Continued)
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a lower EQ-5D-5L-VAS score (68.3 vs. 61.5, p< 0.01) and utilities (0.79 vs. 0.75, p = 0.02).
There weren’t any statistically difference between adherent and nonadherent patients regard
to number of diseases and drugs in our results.
Regarding structural support, neither number of cohabitants nor marital status were associ-
ated to treatment adherence. The mean score for functional support was 43.7 (SD 8.8) out of
55 points; for the confidential domain, 29.5 (SD 5.9) out of 35 points, and for the emotional
domain, 14.2 (SD 3.7) out of 20 points. A statistically significant association was found
between functional support and adherence, both for the total score and its domains (Table 1).
The detailed study of functional support showed significantly different means between
adherent and nonadherent patients for the following items: receiving love and affection (-0.23;
95% CI: -0.40; -0.06), receiving help when sick in bed (-0.25; 95% CI: -0.42;-0.08), receiving
useful advice about important events (-0.20; 95% CI: -0.37;-0.02), receiving social invitations
(-0.22; 95% CI: -0.44;-0.01), and receiving praise and recognition at work (-0.29; 95% CI:
-0.50;-0.08) (Table 2).
In the adjusted models, nonadherence was associated with having a medium vs. high func-
tional support (OR 0.62; 95% CI 0.41–0.94), less than 4 IUVs (OR 0.66; 95% CI 0.44–1.99) and
higher EQ-5D-5L-VAS score (OR 0.98; 95% CI 0.98–0.99) (Tables 3 & 4).
Discussion
Main findings of the study
In patients aged 65–74 years with multimorbidity and polypharmacy, nonadherence to treat-
ment was moderate. Lower functional support was associated with treatment nonadherence in
these patients, although this effect was not consistent across all levels of support. The specific
Table 1. (Continued)
Total n (%) Adherent n (%) Nonadherent n (%) p-value




Table 2. Distribution of the DUFSS questionnaire items according to adherence. Order of items following Ayala´s proposal.
Total Adherent Nonadherent Difference of means p-value
Confidential Domain Mean (SD)
Item 7. I have chances to talk to someone I trust about my personal and family problems 4.2(1.1) 4.1(1.1) 4.2(1.1) -0.05 (-0.24–0.13) 0.56
Item 8. I have chances to talk to someone about money problems 4.1(1.1) 4(1.2) 4.1(1.1) -0.11(-0.29–0.08) 0.25
Item 6. I have chances to talk to someone about problems at work or at home 4.2(1.1) 4.1(1.2) 4.2(1.1) -0.13(-0.31–0.05) 0.17
Item 5. I receive love and affection 4.3(1) 4.2(1.2) 4.4(0.9) -0.23(-0.40-(-0.06)) <0.01
Item 4. I have people who care what happens to me 4.4(1) 4.3(1.1) 4.4(0.9) -0.12(-0.28–0.05) 0.16
Item 11. I receive help when I am sick in bed 4.3(1.1) 4.2(1.2) 4.4(0.9) -0.25(-0.42-(-0.08)) <0.01
Item 10. I receive useful advice about important things in my life 4(1.1) 3.9(1.1) 4.1(1) -0.20(-0.37-(-0.02)) 0.03
Affective Domain Mean (SD)
Item 2. I receive help in matters related to my home 3.1(1.4) 3.1(1.4) 3.1(1.3) -0.05(-0.27–0.33) 0.69
Item 1. I get visits from friends and family 3.6(1.3) 3.5(1.3) 3.7(1.3) - 0.17(-0.38–0.04) 0.12
Item 9. I receive invitations to participate in activities and go out with other people 3.8(1.3) 3.7(1.3) 3.9(1.2) -0.22(-0.44-(-0.01)) 0.04
Item 3. I receive praise and recognition when I do my job well 3.6(1.3) 3.5(1.3) 3.8(1.2) -0.29(-0.50-(-0.08)) <0.01
https://doi.org/10.1371/journal.pone.0235148.t002
PLOS ONE Social support, social context and nonadherence. MULTIPAP Study
PLOS ONE | https://doi.org/10.1371/journal.pone.0235148 June 24, 2020 6 / 15
Table 3. Factors associated with nonadherence to treatment in patients with multimorbidity and polypharmacy.
Model 0 Model 1 Model 2 Model 3
OR (CI 95%) p-value OR (CI 95%) p-value OR (CI 95%) p-value OR (CI 95%) p-value
Functional support 1st tertile (low) ref ref ref ref
2nd tertile (medium) 0.58(0.38–0.87) <0.010 0.59(0.39–0.89) 0.01 0.61(0.40–0.92) 0.02 0.62(0.41–0.94) 0.03
3rd tertile (high) 0.64(0.41–1.02) .06 0.65(0.41–1.04) 0.07 0.71(0.45–1.12) 0.14 0.72(0.45–1.14) 0.16
Age --- 1.00(0.93–1.06) 0.75 0.99(0.93–1.06) 0.87 1.00(0.93–1.06) 0.92
Sex ---
Female ref ref ref
Male 1.07(0.75–1.53) 0.71 1.08(0.76–1.54) 0.68 1.19(0.83–1.71) 0.34
Retirement status
Retired --- ref ref ref ref ref
Nonretired 1.19(0.59–2.38) 0.62 1.23(0.61–2.47) 0.56 1.28(0.64–2.57) 0.49
Social class ---
Unskilled ref ref ref
Skilled primary sector 0.92(0.61–1.38) 0.69 0.92(0.61–1.38) 0.68 0.96(0.69–1.46) 0.84
Mid-level supervisors and directors 0.72(0.44–1.18) 0.20 0.71(0.43–1.18) 0.18 0.77(0.46–1.29) 0.31
Education level ---
Primary incomplete ref ref ref
Primary education 0.99(0.66–1.47) 0.95 0.98(0.66–1.45) 0.91 1.03(0.69–1.53) 0.90
Secondary or higher education 1.20(0.66–2.19) 0.55 1.24(0.68–2.29) 0.49 1.27(0.68–2.38) 0.44
Socioeconomic level ---
�1050€/month ref ref ref
1051–2250€/month 1.26(0.84–1.87) 0.26 1.24(0.83–1.84) 0.30 1.18(0.79–1.77) 0.41
�2251€/month 1.12(0.58–2.13) 0.74 1.10(0.57–2.11) 0.77 1.08(0.56–2.09) 0.82
NS/NC 1.96(0.77–4.98) 0.16 2.12(0.83–5.45) 0.12 1.80(0.73–4.44) 0.20
Urban vulnerability indicators --- ---
�4 indicators ref 0.03 ref 0.05
<4 indicators 0.62(0.41–0.94) 0.66(0.44–0.99)
Number of diseases --- --- --- 0.99(0.92–1.07) 0.85
Number of drugs --- --- --- 0.95(0.88–1.03) 0.22
EQ-5D-5L-VAS --- --- --- 0.98(0.97–0.99) <0.01
Utilities --- --- --- 1.10(0.36–3.38) 0.87
Pseudo R2 0.0099 0.0168 0.0253 0.0418
https://doi.org/10.1371/journal.pone.0235148.t003
Table 4. Factors associated with nonadherence to treatment in patients with multimorbidity and polypharmacy.
Final model with those variables that were significantly associated in Table 3.
OR (CI 95%) p-value
Functional support
1st tertile (low) ref
2nd tertile (medium) 0.62(0.42–0.94) 0.023




<4 indicators 0.69(0.46–1.02) 0.061
Number of drugs 0.94(0.88–1.01) 0.085
Pseudo R2 0.0354
https://doi.org/10.1371/journal.pone.0235148.t004
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items associated with nonadherence were those related to affection, help in the disease, advice,
social invitations and recognition. Nonadherence to treatment was associated with greater
urban vulnerability and lower health-related quality of life.
Strengths and comparison with other studies
Among the strengths of our study, it is worth mentioning, on the one hand, the selected popu-
lation, representative of the general population with these characteristics and hardly studied in
previous research. The older youth with multi-morbidity and polypharmacy is a very frequent
population among the adult population in most Western European countries, with a great
potential for action in terms of optimizing adherence to treatment. On the other hand, the
study of socioeconomic factors with nonadherence to treatment -with special emphasis on
functional support-. Furthermore, the models were adjusted by a large number of clinical,
sociodemographic and urban vulnerability variables, which favors a better understanding of
the mechanisms underlying the associations found.
The nonadherence to treatment in our study is somewhat lower than that obtained in the
meta-analysis conducted by Naderi et al. (43% in patients with an average age of 64 years), and
another study by Alves et al. in which a prevalence of 50% was found in a population with mul-
timorbidity and with a mean age of 56.5 years [34,35]. These differences can be explained by
the age ranges included in each of the studies, where, as reported by Feehan et al., younger age
is associated with lower levels of adherence [36].
In relation to the influence of functional support on treatment adherence, it is difficult to
compare our results with those obtained in other studies because of differences in study popu-
lations, questionnaires and theoretical frameworks. A study conducted in the field of psychol-
ogy concluded that there is an inverse association between social support and nonadherence,
without obtaining a statistical significance. However, it excluded people over 65 years of age
with multiple chronic diseases [7]. In a meta-analysis by Dimatteo et al., they found no statisti-
cal significance in the association between structural support and nonadherence to treatment,
although they did find a significant association for functional support [19], as was the case in
our study. A study by Mondesir et al., conducted in a population of chronic patients with a
mean age of 66.2 years, found that having care support while having a disease or disability
increased adherence to treatment [25], which coincides with the results obtained for item 11 of
the DUFSS scale in our study.
An interpretative qualitative meta-analysis that had, among others, the objective of exploring
the experiences lived by patients in the context of multimorbidity indicated that patients who
have structural support may feel isolated if they believe that people in their environment do not
want to understand their problems [37]. Additionally, another qualitative study on patients
with chronic obstructive pulmonary disease concluded that this sense of incomprehension from
their environment can lead people to passively cope with their disease [38]. Items that relate to
the need to speak or receive support for aspects beyond the disease were not significantly associ-
ated with nonadherence in our study, but this may be due to the social needs and lifelong char-
acteristics of the people who make up the sample. In young seniors individuals, their needs for
social support could be more related to maintaining their affective, social and recognition rela-
tionships, requiring explicit help only for important events and situations of illness.
In the present study, indicators of subjective urban vulnerability were related to nonadher-
ence. Two recent qualitative studies concluded that neighborhoods affect the health of resi-
dents by creating a social context that directly influences their beliefs and behaviors, such as
adherence to prescribed treatment [39,40]. The fact that in our study nonadherence was asso-
ciated with urban vulnerability and not with social class or income level could be because
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people in this age range have more homogenous salaries coming from their pensions despite
living in communities with varying social statuses. The urban vulnerability indicators may cap-
ture such heterogeneity in the socioeconomic and social class of the study patients throughout
their working life. However, more studies are needed to delve into this relationship.
Regarding the state of perceived health according to the health-related quality of life VAS,
the score obtained in our study is similar to that of another study performed in our country
with people over 65 years of age who were not institutionalized, for whom a mean score of
66.6 (95% CI 65.3–68) was observed [41]. A worse perceived health-related quality of life has
been previously associated with nonadherence to treatment. Alves et al. [35] found that nonad-
herence to treatment was associated with a poorer health-related quality of life in patients with
chronic kidney disease. On the other hand, Mclane C. et al. found that patients with a better
health-related quality of life had higher nonadherence rates, given that their health problem
did not affect their daily routine [42].
Concerning the number of diseases and the number of drugs, which in other studies have been
associated with adherence to treatment [39,43], these were not statistically significant in our case.
This could be due to the fact that ours is a very homogeneous sample with respect to the clinical
variables collected, since all of the patients presented multimorbidity and polypharmacy.
Limitations
Methods for measuring adherence to treatment based on self-reported information may have
certain limitations due to recall bias, social desirability and faults in self- observation [44].
However, the Morisky-Green test has been validated and has high specificity, a high positive
predictive value and is easy to perform [27]; therefore, it is widely used.
In relation to social support, there are different definitions and measurement instruments
depending on the study discipline. Even studies carried out in the field of health that use the
DUFSS questionnaire to measure functional support present important differences concerning
the items included in the different domains and the reporting of results. This questionnaire
has been validated in different population groups [45–49]. Among the Spanish validations,
three of the studies were conducted in primary care. Among them, De la Revilla et al. and Bel-
lón et al. validated it for socioeconomically disadvantaged women in the general population
[28,50]. Cuellar-Flores et al. and Mas-Expósito et al. validated the instrument in caregivers and
mental health patients [51,52]. In our study, we chose to use the most recent validation per-
formed by Ayala et al. [30] in people 60 years or older who were not institutionalized given the
similarities with our population. As for the interpretation of the results, there is also variability
because authors can report their results either qualitative or quantitatively. In this study, we
did not limit our exposure to the level of support, taking into account the subjectivity and vari-
ability of this interpretation depending on social, economic and cultural contexts [53].
Adherence is influenced by a large number of factors. Haynes estimated up to 250 factors
[11], many of which have not been included in our study. This may explain why the relation-
ship between nonadherence and social support does not hold up for higher levels of support.
The study of the social context implies the difficulty of studying strongly related multidi-
mensional concepts. In order to study the social context, the present work collects the educa-
tional level, social class, educational level, physical environment through the indicators of
subjective urban vulnerability and the monthly income of the family unit.
Implications of the study findings
By knowing the role that social support plays in relation to health behaviors and adherence,
health professionals can anticipate a more effective approach, taking into account the
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socioeconomic context of the patient, their health-related quality of life and preferences. The
results of this study reveal that therapeutic nonadherence is not related to the quantification of
the structural support of the person but, rather, to the importance that people confer to the
support they receive and when they receive it. The perception of these patients concerning the
environment in which they live and their health-related quality of life seems to explain this
association too. Both urban vulnerability and health-related quality of life are complex and
multidimensional concepts conditioned by the subjective perception of the person, reflecting
aspects linked to both the physical and social environment, as well as individual-level life and
health experiences. It is therefore essential to integrate these patient-reported outcomes in clin-
ical practice to improve the care of older people with multimorbidity, enabling also to individ-
ualize their treatments and increase their involvement in self-care.
Acknowledgments
To our colleagues from the Research Unit Primary Health Care Management Madrid for their
support. To all the professionals from the participant Primary Healthcare Centers. To all
patients for their contribution to this research.
MULTIPAP GROUP
Lead authors for the MULTIPAP Study group: Alexandra Prados Torres (Aragonese Insti-
tute of Health Sciences (IACS), IIS Aragón, Miguel Servet University Hospital, Spain) sprados.
iacs@aragon.es, Juan Daniel Prados Torres (Multiprofessional Teaching Unit for Family and
Community Care Primary Care District Málaga-Guadarhorce. Málaga) juand.prados.sspa@-
juntadeandalucia.es, Isabel del Cura (Research unit. Primary Health Care Management
Madrid. Spain) isabel.cura@salud.madrid.org.
Coordinating Committee
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Methodology: Cristina M. Lozano-Hernández, Francisca Leiva-Fernández, Luis A. Gimeno-
Feliu, Isabel del Cura-González.
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Supervision: Isabel del Cura-González.
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cisca Leiva-Fernández, Amaia Calderón-Larrañaga, Jaime Barrio-Cortes, Luis A. Gimeno-
Feliu, Isabel del Cura-González.
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